SG Americas Securities
AVIR icon

SG Americas Securities’s Atea Pharmaceuticals AVIR Stock Holding History

SG Americas Securities’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,742
Closed -$38K – 3219
2025
Q4 		$38K Sell
10,742
-9,719
-48% -$30.9K ﹤0.01% 3397
2025
Q3 		$59K Buy
+20,461
New +$69.9K ﹤0.01% 3175
2025
Q2 		– Sell
-32,520
Closed -$97K – 2937
2025
Q1 		$97K Buy
32,520
+422
+1% +$1.32K ﹤0.01% 3059
2024
Q4 		$108K Buy
32,098
+1,486
+5% +$4.94K ﹤0.01% 2684
2024
Q3 		$103K Buy
30,612
+16,561
+118% +$60K ﹤0.01% 3047
2024
Q2 		$47K Sell
14,051
-14,089
-50% -$52.5K ﹤0.01% 2681
2024
Q1 		$114K Sell
28,140
-14,381
-34% -$56.3K ﹤0.01% 2455
2023
Q4 		$130K Buy
42,521
+8,024
+23% +$24.3K ﹤0.01% 2534
2023
Q3 		$103K Buy
+34,497
New +$117K ﹤0.01% 2777
2023
Q2 		– Sell
-31,179
Closed -$104K – 2305
2023
Q1 		$104K Sell
31,179
-7,863
-20% -$31.9K ﹤0.01% 2880
2022
Q4 		$188K Sell
39,042
-39,797
-50% -$201K ﹤0.01% 2240
2022
Q3 		$449K Buy
78,839
+13,519
+21% +$103K 0.01% 1641
2022
Q2 		$464K Buy
+65,320
New +$446K ﹤0.01% 2021
2022
Q1 		– Sell
-17,361
Closed -$155K – 2960
2021
Q4 		$155K Sell
17,361
-20,323
-54% -$317K ﹤0.01% 2803
2021
Q3 		$1.32M Buy
+37,684
New +$1.05M 0.01% 1667
2021
Q2 		– Sell
-2,119
Closed -$131K – 2853
2021
Q1 		$131K Buy
+2,119
New +$143K ﹤0.01% 2935

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

SG Americas Securities's AVIR Position: Q1 2026 in Review

SG Americas Securities sold out of Atea Pharmaceuticals (AVIR) in Q1 2026, closing a stake of 10,742 shares — an estimated $38K sold.

SG Americas Securities first reported a position in AVIR in Q1 2021 and held it in 16 quarters. The position peaked at $1.32M in Q3 2021. 127 funds tracked by Wall St. Rank hold AVIR as of Q1 2026.

  • SG Americas Securities reported no remaining Atea Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 10,742 Atea Pharmaceuticals shares in Q1 2026, an estimated $38K.
  • SG Americas Securities first reported a position in Atea Pharmaceuticals in Q1 2021 and held it in 16 quarters.
  • SG Americas Securities's Atea Pharmaceuticals position peaked at $1.32M in Q3 2021.
  • 127 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.